The human immunodeficiency virus (HIV) primarily spreads through specific risky behaviors and circumstances. The most common transmission pathways include sharing contaminated needles among intravenous drug users, transfer through blood transfusions when the blood isn't properly screened, and from mother to child during pregnancy, childbirth, or breastfeeding. Recognizing these modes is crucial for prevention and early intervention.

HIV attacks the body's immune system, particularly targeting CD4 cells, a vital subset of white blood cells essential for fighting infections. Over time, if untreated, HIV can significantly diminish CD4 cell counts, leading to the progression towards Acquired Immunodeficiency Syndrome (AIDS). This progression marks a severe decline in immune function, making individuals vulnerable to opportunistic infections and certain cancers.

HIV transmission through blood products remains a concern, but rigorous screening protocols in healthcare settings have drastically minimized this risk globally. Nonetheless, it remains important to be aware of potential hazards, especially in areas where blood screening procedures may be less stringent.

The risk of mother-to-child transmission emphasizes the importance of prenatal care and appropriate medical interventions. When mothers receive antiretroviral therapy during pregnancy and delivery, and infants are given preventive treatment after birth, the chances of transmission are significantly reduced.

While many people infected with HIV do not immediately develop symptoms, understanding the stages of infection helps in early detection and management. The initial or acute phase occurs within 4 to 6 weeks post-infection, characterized by flu-like symptoms, including fever, sore throat, headaches, muscle, and joint pains, as well as swelling of lymph nodes. During this period, the virus replicates rapidly, and individuals are highly infectious.

The clinical latent or chronic phase follows, often lasting several years, especially with consistent antiretroviral therapy. During this stage, many individuals remain asymptomatic, though the virus persists and gradually weakens the immune system by reducing CD4 cell counts. Swollen lymph nodes may be the only visible sign, providing a clue to ongoing infection.

Progression to AIDS signifies advanced immune suppression. When CD4 cell counts fall below 200 cells per cubic millimeter of blood, the disease is classified as AIDS. Manifestations include recurring fevers, unintended weight loss, persistent diarrhea, chronic fatigue, night sweats, skin rashes, and mouth sores. These symptoms stem from opportunistic infections and illnesses that take advantage of the compromised immune system.

It's important to note that, with current medical treatments, many individuals living with HIV can maintain a near-normal quality of life for decades without developing AIDS. However, without effective therapy, the progression to AIDS is inevitable, and it remains a global health challenge due to the lack of a definitive cure. Prevention, early detection, and continuous treatment are cornerstone strategies in managing HIV/AIDS.